976. Deputy Cormac Devlin asked the Minister for Health the number of lipid profiles ordered through primary care (GP and primary care clinics) in each of the years 2019 to date in 2025, by CHO area and by quarter, in tabular form; and if she will make a statement on the matter. [61316/25]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Cormac Devlin under the heading Health Screening Programmes.
10 questions match, newest first.
977. Deputy Cormac Devlin asked the Minister for Health the total cost to the health service from 2019 to 2025, by year for laboratory testing for standard lipid profiles ordered from primary care, including the cost per test and any trend in test volumes over that period; and if she will make a statement on the matter. [61317/25]
978. Deputy Cormac Devlin asked the Minister for Health the number of lipoprotein(a) [Lp(a)] tests carried out in public hospitals and HSE-funded laboratories from 2019 to 2025, by referral source (primary care versus hospital-based specialist services), by year, in tabular form; and if she will make a statement on the matter. [61318/25]
979. Deputy Cormac Devlin asked the Minister for Health if current national guidelines on cardiovascular risk assessment in primary care recommend measurement of lipoprotein(a) [Lp(a)] for any cohort of patients; the rationale for current practice; and if she will make a statement on the matter. [61319/25]
980. Deputy Cormac Devlin asked the Minister for Health if she has considered introducing a once-in-a-lifetime lipoprotein(a) [Lp(a)] test as part of routine cardiovascular risk assessment for adults, in line with emerging European recommendations on heart health and inherited risk; and if she will make a statement on the matter. [61320/25]
981. Deputy Cormac Devlin asked the Minister for Health if her Department or the HSE has undertaken any clinical or economic evaluation of the potential benefits and costs of introducing once-in-a-lifetime lipoprotein(a) [Lp(a)] testing for the general population; the details of any such analysis; and if she will make a statement on the matter. [61321/25]
982. Deputy Cormac Devlin asked the Minister for Health the proportion of adults in the State for whom Lp(a) has been measured at least once; the estimated prevalence of elevated lipoprotein(a) [Lp(a)] among those tested; the extent to which this information is used to guide more intensive LDL cholesterol lowering or other preventive measures; and if she will make a statement on the matter. [61322/25]
983. Deputy Cormac Devlin asked the Minister for Health if she will report on any international examples, particularly within the EU, where once-in-a-lifetime lipoprotein(a) [Lp(a)] testing has been adopted or piloted as part of national cardiovascular prevention strategies; if similar pilots are being considered in Ireland; and if she will make a statement on the matter. [61323/25]
984. Deputy Cormac Devlin asked the Minister for Health if she will ensure that future revision of national cardiovascular prevention guidelines for primary care explicitly considers the role of lipoprotein(a) [Lp(a)] testing in identifying people at inherited high risk of heart disease and stroke; if she will report on the timeframe for such guideline updates; and if she will make a statement on the matter. [61324/2…
985. Deputy Cormac Devlin asked the Minister for Health the way in which her Department plans to improve early detection and management of cardiovascular risk in primary care over the next five years, including the role of lipid testing, potential once-in-a-lifetime lipoprotein(a) [Lp(a)] screening, and targeted follow up for high-risk patients; and if she will make a statement on the matter. [61325/25]